Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000003030 | SCV001397515 | pathogenic | Glanzmann thrombasthenia | 2021-03-05 | reviewed by expert panel | curation | The c.1073G>A (p.Arg358His) variant has been reported, in the homozygous state, in at least four probands (PMIDs: 8883261, 25728920, 19691478, 7706461) and once in a compound heterozygous case (PMID: 21557682), several of whom meet all diagnostic criteria for a phenotype highly specific to GT. This variant is absent from ExAC and gnomAD. In summary, this variant meets criteria to be classified as pathogenic for GT. GT-specific criteria applied: PM2_supporting, PM3_strong, and PP4_strong. |
ISTH- |
RCV001580162 | SCV002500890 | pathogenic | Glanzmann thrombasthenia 1 | criteria provided, single submitter | clinical testing | ||
3billion | RCV001580162 | SCV003841457 | pathogenic | Glanzmann thrombasthenia 1 | 2023-02-23 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000002896). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 19691478, 25728920, 7706461, 8883261). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |
OMIM | RCV001580162 | SCV000023188 | pathogenic | Glanzmann thrombasthenia 1 | 2021-04-13 | no assertion criteria provided | literature only |